Follow the 오션스바이오 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 오션스바이오 has logged 1 insider filings. The latest transaction was filed on 4 April 2025 (Sale). Among the most active insiders: 강귀염. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
오션스바이오 operates in the healthcare and pharmaceutical sector, listed on the XKRX. The company focuses on developing innovative biological solutions.